8,325 research outputs found
Intro remarks
No full textIntroduction remarks by:
Ernest Hawk, MD, MPH
Vice President, Division Head Cancer Prevention and Population Science
Michael S. Ewer, MD, MPH, JD, LLM, MBA, Oral History Interview, July 25, 2018
No full textMajor Topics Covered: Education and personal background Service as Medical Officer on a Princess Cruises ship Intensive Care Services at MD Anderson; building the service Views of cardiology versus onco-cardiology; medical education Ethics Committee: formation; composition; evolution; purpose of ethical consults; developing an institutional philosophy of ethics; challenging cases; shifting institutional priorities and effect on ethics Research: cardiotoxicity of chemotherapeutic agents Institutional changehttps://openworks.mdanderson.org/mchv_interviewsessions/1127/thumbnail.jp
Grand Rounds: Research Reproducibility - Jeffrey R. Botkin, MD, MPH (04-03-2018)
No full textSpencer S. Eccles Health Sciences Library Grand Rounds: Research Reproducibility (GRRR). "Causes and Responses to Research Misconduct" by Jeffrey R. Botkin, MD, MPH. GRRR is a weekly endeavor to raise awareness about reproducibility issues, showcase Utah researchers\u27 work, and to create an open forum for discussions. Grand Rounds: Research Reproducibility website: http://campusguides.lib.utah.edu/UtahRR18/GRRR Jeffrey R. Botkin, MD, MPH, Professor of Pediatrics at the University of Utah and an Adjunct Professor of Human Genetics. He is Chief of the Division of Medical Ethics and Humanities in the Department of Internal Medicine. Dr. Botkin is the Associate Vice President for Research Integrity at the University of Utah with oversight responsibilities for the IRB, conflict of interest, responsible conduct of research, biosafety, and research ethics education. bit.ly/JBotki
Michael S. Ewer, MD, MPH, JD, LLM, MBA, Oral History Interview, May 24, 2018
No full textMajor Topics Covered: Education and personal background Service as Medical Officer on a Princess Cruises ship Intensive Care Services at MD Anderson; building the service Views of cardiology versus onco-cardiology; medical education Ethics Committee: formation; composition; evolution; purpose of ethical consults; developing an institutional philosophy of ethics; challenging cases; shifting institutional priorities and effect on ethics Research: cardiotoxicity of chemotherapeutic agents Institutional changehttps://openworks.mdanderson.org/mchv_interviewsessions/1126/thumbnail.jp
Keynote Address: Donald Schwaz, MD, MPH
No full textDr. Donald Schwarz is Deputy Mayor for Health and Opportunity and Health Commissioner for the City of Philadelphia. Before entering government service, he was Vice Chairman of the Department of Pediatrics of the University of Pennsylvania School of Medicine, Deputy Physician-in-Chief and Craig-Dalsimer Division Chief for Adolescent medicine at The Children’s Hospital of Philadelphia and Professor of Pediatrics in the University of Pennsylvania Schools of Medicine and Nursing at The Children’s Hospital of Philadelphia. He was also a senior fellow at the Leonard Davis Institute for Health Economics at Penn.
Dr. Schwarz was an active researcher in the area of adolescent risk behaviors for over 22 years, and received both public and private funding for work that has examined the issues of injury and its prevention in urban, minority communities, public policy approaches to adolescent violence, and physician- and nurse-practice-based interventions to improve outcomes for high-risk infants. Dr. Schwarz served for four years as President of the Board of Directors of Philadelphia Citizens for Children and Youth, has been a member of the Governing Council of the American Public Health Association, and is a Board member of numerous local and regional community agencies.
Dr. Schwarz is a graduate of Brown University where is received an AB in Biology. He received an MD and MPH in Health Care Organization, and an MBA in Health Care Administration at the Wharton School of the University of Pennsylvania
OncoLog, Volume 50, Number 04, April 2005
No full textHarnessing the Immune System: The Promise and Potential of Cancer Vaccines Considering Prophylactic Surgery House Call: Chemotherapy and Hair Loss DiaLog: Redefining Success in Cancer Care, by Michael Fisch, MD, MPH, Medical Director, Community Clinical Oncology Programhttps://openworks.mdanderson.org/oncolog/1148/thumbnail.jp
Michael J. Fisch, MD, Oral History Interview, February 13, 2015
No full textGeneral Topics Covered: History of and observations about the evolving field of General Medical Oncology Relationships between general medical oncology, supportive care, and palliative care Integrating these practices into MD Anderson treatment programs Research into patient experience and symptom management Anecdotes about work with patients at MD Anderson and VIP patients overseashttps://openworks.mdanderson.org/mchv_interviewsessions/1131/thumbnail.jp
Linda Elting, PhD, MPH, Oral History Interview, April 23, 2015
No full textMajor Topics Covered: History of MD Anderson Institutional Review Boards Women’s careers at MD Anderson Mentoring researchers and leaders MD Anderson growth and changes to MD Anderson culturehttps://openworks.mdanderson.org/mchv_interviewsessions/1115/thumbnail.jp
Michael J. Fisch, MD, Oral History Interview, February 18, 2015
No full textGeneral Topics Covered: Research into patient experience and symptom management Anecdotes about work with patients at MD Anderson and VIP patients overseas Social media and its potential for use in healthcarehttps://openworks.mdanderson.org/mchv_interviewsessions/1132/thumbnail.jp
Chapter 26: MD Anderson’s Focus on Patient Experience
No full textDr. Fisch talks about two initiatives to involve patients as partners in planning processes: the Patient Experience Steering Committee and the Patient and Family Advisory Council. Dr. Fisch notes that though he received invitations to serve on both committees, he was given no charge or mission and there is no natural momentum on patient experience at the institution. He talks about the advantages to the institution of addressing patient experience and notes that MD Anderson’s attention to this matter is a response to an Institute of Medicine report that other institutions are moving ahead.
Dr. Fisch then observes that if an institution is not patient-centered, shifting focus is difficult. He suggests ways in which MD Anderson communicates that it is not patient centered. He then talks about Leadership Rounds, which help leaders see the institution from a patient’s perspective. He acknowledges that the institution is listening to patients more and coming up with creative ways of reorganizing care.
At the end of the session, he makes some final comments about working at MD Anderson.https://openworks.mdanderson.org/mchv_interviewchapters/1846/thumbnail.jp
- …
